Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer

The metastasis and poor prognosis are still regarded as the main challenge in the clinical treatment of breast cancer (BC). Both N6-methyladenosine (m6A) modification and lncRNAs play vital roles in the carcinogenesis and evolvement of BC. Considering the unknown association of m6A and lncRNAs in BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Wenchang, Wang, Yichen, Zhao, Chongru, Tan, Yufang, Xiong, Mingchen, Yi, Yi, He, Xiao, Ren, Yuping, Wu, Yiping, Zhang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555664/
https://www.ncbi.nlm.nih.gov/pubmed/34722303
http://dx.doi.org/10.3389/fonc.2021.745719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555664/
https://www.ncbi.nlm.nih.gov/pubmed/34722303
http://dx.doi.org/10.3389/fonc.2021.745719

Ejemplares similares